Asia · Financial press · SCMP Business
China’s Hengrui posts 89% rise in third-quarter net profit, beating estimates
Jiangsu Hengrui Pharmaceuticals, one of China’s largest drug makers, reported a 20.55 per cent rise in third-quarter revenue to 8.95 billion yuan (US$1.34 billion), beating…
Read the full article on SCMP Business Sign in to saveMarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.scmp.com)
